Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (198) 198
gastroenterology & hepatology (175) 175
male (168) 168
female (113) 113
middle aged (103) 103
aged (87) 87
adult (81) 81
animals (72) 72
index medicus (57) 57
rats (46) 46
oncology (45) 45
gastroenterology (41) 41
hepatocellular carcinoma (41) 41
hepatology (39) 39
liver (39) 39
electric communication technique (38) 38
electricity (38) 38
interferon (35) 35
medicine & public health (35) 35
biopsy (34) 34
fibrosis (34) 34
mice (34) 34
japan (33) 33
expression (30) 30
fatty liver (30) 30
hepatitis c (30) 30
liver - pathology (30) 30
transmission of digital information, e.g. telegraphiccommunication (30) 30
hepatitis c virus (29) 29
oxidative stress (29) 29
analysis (27) 27
cirrhosis (26) 26
non-alcoholic fatty liver disease (26) 26
rats, wistar (26) 26
cancer (25) 25
hepatocellular-carcinoma (25) 25
colorectal surgery (24) 24
surgical oncology (24) 24
chronic hepatitis c (23) 23
infection (23) 23
multiplex communication (23) 23
carcinoma, hepatocellular - pathology (22) 22
nonalcoholic steatohepatitis (22) 22
testing (22) 22
insulin resistance (21) 21
investigating or analysing materials by determining theirchemical or physical properties (21) 21
measuring (21) 21
physics (21) 21
aged, 80 and over (20) 20
fatty liver-disease (20) 20
liver neoplasms - pathology (20) 20
retrospective studies (20) 20
alanine transaminase - blood (19) 19
apoptosis (19) 19
immunohistochemistry (19) 19
insulin-resistance (19) 19
liver - metabolism (19) 19
liver diseases (19) 19
natural-history (19) 19
severity of illness index (19) 19
transmission (19) 19
biochemistry & molecular biology (18) 18
genotype (18) 18
risk factors (18) 18
steatohepatitis (18) 18
therapy (18) 18
antiviral agents - therapeutic use (17) 17
gastroenterology and hepatology (17) 17
hepatitis b virus - genetics (17) 17
hepatitis c, chronic - drug therapy (17) 17
liver cirrhosis (17) 17
time factors (17) 17
treatment outcome (17) 17
carcinoma, hepatocellular - genetics (16) 16
care and treatment (16) 16
cells (16) 16
dna (16) 16
ferritin (16) 16
genetic aspects (16) 16
liver cancer (16) 16
mutation (16) 16
ribavirin (16) 16
risk (16) 16
cell biology (15) 15
chronic disease (15) 15
cell line, tumor (14) 14
development and progression (14) 14
hepatitis (14) 14
internal medicine (14) 14
metabolic syndrome (14) 14
prognosis (14) 14
association (13) 13
interferons - therapeutic use (13) 13
liver neoplasms - genetics (13) 13
nafld (13) 13
reverse transcriptase polymerase chain reaction (13) 13
thioredoxin (13) 13
abdominal surgery (12) 12
diagnosis (12) 12
disease (12) 12
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study
by Tateishi, Ryosuke and Okanoue, Takeshi and Fujiwara, Naoto and Okita, Kiwamu and Kiyosawa, Kendo and Omata, Masao and Kumada, Hiromitsu and Hayashi, Norio and Koike, Kazuhiko
Journal of Gastroenterology, ISSN 0944-1174, 2015, Volume 50, Issue 3, pp. 350 - 360
The number of hepatocellular carcinoma (HCC) patients with non-viral etiologies is increasing in Japan. We conducted a nation-wide survey to examine the... 
Hepatocellular carcinoma | Retrospective study | Non-alcoholic fatty liver disease | Non-alcoholic steatohepatitis | Alcoholic liver disease | LIVER-CANCER | CHRONIC HEPATITIS-B | CIRRHOSIS | JAPAN | RISK | INFECTION | GASTROENTEROLOGY & HEPATOLOGY | Japan - epidemiology | Carcinoma, Hepatocellular - epidemiology | Prognosis | Humans | Middle Aged | Male | Liver Neoplasms - therapy | Hepatitis, Viral, Human - epidemiology | Liver Neoplasms - etiology | Non-alcoholic Fatty Liver Disease - complications | Liver Cirrhosis, Biliary - epidemiology | Liver Neoplasms - epidemiology | Female | Hepatitis, Autoimmune - epidemiology | Hepatitis, Viral, Human - complications | Carcinoma, Hepatocellular - etiology | Retrospective Studies | Body Mass Index | Liver Diseases, Alcoholic - epidemiology | Carcinoma, Hepatocellular - diagnosis | Risk Factors | Hepatitis, Autoimmune - complications | Liver Neoplasms - diagnosis | Survival Analysis | Liver Diseases, Alcoholic - complications | Aged | Carcinoma, Hepatocellular - therapy | Liver Cirrhosis, Biliary - complications | Non-alcoholic Fatty Liver Disease - epidemiology | Cohort Studies | Alcoholics | Development and progression | Hepatoma | Liver cirrhosis | Original —Liver, Pancreas, and Biliary Tract
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese
by Kawaguchi, Takahisa and Sumida, Yoshio and Umemura, Atsushi and Matsuo, Keitaro and Takahashi, Meiko and Takamura, Toshinari and Yasui, Kohichiroh and Saibara, Toshiji and Hashimoto, Etsuko and Kawanaka, Miwa and Watanabe, Sumio and Kawata, Sumio and Imai, Yasuharu and Kokubo, Miki and Shima, Toshihide and Park, Hyohun and Tanaka, Hideo and Tajima, Kazuo and Yamada, Ryo and Matsuda, Fumihiko and Okanoue, Takeshi and JSG-NAFLD and Takeshi Okanoue4 for the Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD)
PLoS ONE, ISSN 1932-6203, 06/2012, Volume 7, Issue 6, p. e38322
Background: Nonalcoholic fatty liver disease (NAFLD) includes a broad range of liver pathologies from simple steatosis to cirrhosis and fibrosis, in which a... 
STEATOHEPATITIS | I148M | VARIANT | MULTIDISCIPLINARY SCIENCES | SUSCEPTIBILITY | Medical research | Fatty liver | Analysis | Genes | Genomics | Genetic research | Medicine, Experimental | Genetic aspects | Hyaluronic acid | Liver cirrhosis | Genetic polymorphisms | Haplotypes | Liver | Genomes | Iron | Single-nucleotide polymorphism | Metabolic syndrome | Epidemiology | Subgroups | Liver cancer | Rodents | Hepatology | Gastroenterology | Population | Degeneration | Genetic factors | Bioinformatics | Drug dosages | Chromosomes | Deoxyribonucleic acid--DNA | University graduates | Liver diseases | Internal medicine | Principal components analysis | Patients | Steatosis | Disease prevention | Medicine | Studies | Cirrhosis | Hospitals | Rheumatoid arthritis | Fibrosis | Biomarkers | Chromosome 22 | Genetic testing | Deoxyribonucleic acid | DNA
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Manual Proposed by the Japan Society of Hepatology
by Kudo, Masatoshi and Okanoue, Takeshi and Clin Pract Manual HCC Expert Panel and Japan Society of Hepatology
Oncology, ISSN 0030-2414, 12/2007, Volume 72, Issue 1, pp. 2 - 15
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer death not only in Japan but worldwide. Clinical Practice Guidelines for HCC were... 
Paper | Consensus-based clinical practice manual | Evidence-based clinical practice guideline | Clinical practice guidelines, manual | Hepatocellular carcinoma, staging, surveillance, diagnostic algorithm, treatment algorithm | diagnostic algorithm | consensus-based clinical practice manual | HEPATIC ARTERIOGRAPHY | ADENOMATOUS HYPERPLASIA | PRACTICE GUIDELINES | JIS SCORE | manual | NATURAL-HISTORY | PROGNOSTIC STAGING SYSTEM | DYSPLASTIC NODULES | treatment algorithm | Clinical practice guidelines | evidence-based clinical practice guideline | ONCOLOGY | CIRRHOTIC LIVERS | surveillance | CLIP SCORE | staging | PATHOLOGICAL CORRELATION | hepatocellular carcinoma | Liver Transplantation | Age Factors | Humans | Middle Aged | Palliative Care | Liver Neoplasms - therapy | Antineoplastic Agents - administration & dosage | Embolization, Therapeutic | Hepatectomy | Societies, Medical | Carcinoma, Hepatocellular - blood supply | Liver Neoplasms - pathology | Liver Neoplasms - virology | Diagnosis, Differential | Carcinoma, Hepatocellular - diagnosis | Japan | Hepatic Artery | Carcinoma, Hepatocellular - virology | Evidence-Based Medicine | Consensus | Algorithms | Liver Neoplasms - diagnosis | Liver Neoplasms - blood supply | Carcinoma, Hepatocellular - pathology | Aged | Carcinoma, Hepatocellular - therapy | Decision Trees | Neoplasm Staging | Population Surveillance | Infusions, Intra-Arterial | Practice Guidelines as Topic | Medical diagnosis | Evidence-based medicine | Liver | Medical treatment | Cancer | Guidelines
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Once-daily simeprevir with peginterferon and ribavirin for treatment-experienced HCV genotype 1-infected patients in Japan: the CONCERTO-2 and CONCERTO-3 studies
by Izumi, Namiki and Hayashi, Norio and Kumada, Hiromitsu and Okanoue, Takeshi and Tsubouchi, Hirohito and Yatsuhashi, Hiroshi and Kato, Mai and Ki, Rito and Komada, Yuji and Seto, Chiharu and Goto, Shoichiro
Journal of Gastroenterology, ISSN 0944-1174, 5/2014, Volume 49, Issue 5, pp. 941 - 953
Efficacy of available therapies for patients with HCV who have previously failed treatment is limited. Two Phase III, open-label trials in Japan investigated... 
Simeprevir | Chronic hepatitis C | Medicine & Public Health | Colorectal Surgery | Treatment-experienced | Hepatology | Gastroenterology | Abdominal Surgery | Surgical Oncology | Sustained virologic response | TMC435 | TELAPREVIR | CHRONIC HEPATITIS-C | SUSTAINED VIROLOGICAL RESPONSE | PROTEASE INHIBITOR | INTERFERON-ALPHA-2B PLUS RIBAVIRIN | PEGYLATED INTERFERON | RESISTANCE | BOCEPREVIR | RETREATMENT | GASTROENTEROLOGY & HEPATOLOGY | EPIDEMIOLOGY | Recombinant Proteins - therapeutic use | Recurrence | Humans | Middle Aged | Hepacivirus - genetics | Polyethylene Glycols - adverse effects | Male | Recombinant Proteins - adverse effects | Polyethylene Glycols - therapeutic use | Young Adult | Ribavirin - administration & dosage | Adult | Female | Drug Therapy, Combination | Hepacivirus - isolation & purification | Drug Administration Schedule | Antiviral Agents - therapeutic use | Japan | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Genotype | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Polyethylene Glycols - administration & dosage | Recombinant Proteins - administration & dosage | Interferon-alpha - administration & dosage | Sulfonamides - therapeutic use | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Heterocyclic Compounds, 3-Ring - administration & dosage | Heterocyclic Compounds, 3-Ring - adverse effects | Heterocyclic Compounds, 3-Ring - therapeutic use | Sulfonamides - adverse effects | Aged | Interferon-alpha - adverse effects | Sulfonamides - administration & dosage | Medical research | Care and treatment | Medicine, Experimental | Genetic aspects | Interferon | Hepatitis C | Hepatitis C virus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text High expression of p300 in HCC predicts shortened overall survival in association with enhanced epithelial mesenchymal transition of HCC cells
by Yokomizo, Chihiro and Yamaguchi, Kanji and Itoh, Yoshito and Nishimura, Takeshi and Umemura, Atsushi and Minami, Masahito and Yasui, Kohichiroh and Mitsuyoshi, Hironori and Fujii, Hideki and Tochiki, Nozomi and Nakajima, Tomoki and Okanoue, Takeshi and Yoshikawa, Toshikazu
Cancer Letters, ISSN 0304-3835, 2011, Volume 310, Issue 2, pp. 140 - 147
Highlights â–º P300 is highly expressed in 47% of surgically resected HCC specimens by immunohistochemistry. â–º High expression of p300 in HCCs is a predictor of... 
Hematology, Oncology and Palliative Medicine | HCC | Overall survival | E-cadherin | P300 | Tumor invasion | FACTOR-I HIF-1 | TRANSCRIPTIONAL COACTIVATOR P300 | BINDING-PROTEIN | BREAST-CANCER | INVASION | ONCOLOGY | GROWTH | HUMAN HEPATOCELLULAR-CARCINOMA | CANCER PROGRESSION | FREQUENT LOSS | E1A-Associated p300 Protein - biosynthesis | Immunohistochemistry | RNA, Small Interfering - genetics | Humans | Middle Aged | E1A-Associated p300 Protein - genetics | Immunoblotting | Male | Cadherins - biosynthesis | Carcinoma, Hepatocellular - genetics | Epithelial-Mesenchymal Transition | Female | Liver Neoplasms - pathology | Cadherins - genetics | Cell Dedifferentiation - physiology | Liver Neoplasms - genetics | Down-Regulation | Carcinoma, Hepatocellular - surgery | Liver Neoplasms - surgery | Cyclin D1 - biosynthesis | Cyclin D1 - genetics | Carcinoma, Hepatocellular - pathology | Liver Neoplasms - metabolism | Survival Analysis | Cell Line, Tumor | Aged | Biomarkers, Tumor - genetics | Apoptosis - physiology | Neoplasm Staging | RNA, Small Interfering - administration & dosage | Biomarkers, Tumor - biosynthesis | Carcinoma, Hepatocellular - metabolism | Prognosis | Tumor proteins | Patient outcomes | Stem cells | Liver cancer | Hepatitis | Angiogenesis | Medical prognosis | Hypoxia | Gene expression | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease
by Park, Hyohun and Park, Hyohun and Shima, Toshihide and Shima, Toshihide and Yamaguchi, Kanji and Yamaguchi, Kanji and Mitsuyoshi, Hironori and Mitsuyoshi, Hironori and Minami, Masahito and Minami, Masahito and Yasui, Kohichiroh and Yasui, Kohichiroh and Itoh, Yoshito and Itoh, Yoshito and Yoshikawa, Toshikazu and Yoshikawa, Toshikazu and Fukui, Michiaki and Fukui, Michiaki and Hasegawa, Goji and Hasegawa, Goji and Nakamura, Naoto and Nakamura, Naoto and Ohta, Mitsuhiro and Ohta, Mitsuhiro and Obayashi, Hiroshi and Obayashi, Hiroshi and Okanoue, Takeshi and Okanoue, Takeshi
Journal of Gastroenterology, ISSN 0944-1174, 1/2011, Volume 46, Issue 1, pp. 101 - 107
Hyperlipidemia, insulin resistance, and oxidative stress can heavily contribute to the initiation and progression of nonalcoholic fatty liver disease (NAFLD).... 
NAFLD | Medicine & Public Health | Fatty acid metabolism | Colorectal Surgery | Hepatology | Gastroenterology | Ezetimibe | Internal Medicine | Oncology | Insulin resistance | Lipid metabolism | Surgical Oncology | CONTROLLED-TRIAL | METFORMIN | VITAMIN-E | CLINICAL-TRIAL | ACIDS | OPEN-LABEL | VLDL1 | DIET | INSULIN-RESISTANCE | STEATOHEPATITIS | GASTROENTEROLOGY & HEPATOLOGY | Liver - pathology | Drug Administration Schedule | Fatty Liver - blood | Fatty Liver - pathology | Humans | Middle Aged | Male | Treatment Outcome | Biomarkers - blood | Fatty Liver - drug therapy | Anticholesteremic Agents - therapeutic use | Azetidines - administration & dosage | Azetidines - therapeutic use | Biopsy | Anticholesteremic Agents - administration & dosage | Liver Cirrhosis - classification | Non-alcoholic Fatty Liver Disease | Liver Cirrhosis - pathology | Adult | Female | Care and treatment | Low density lipoproteins | Anticholesteremic agents | Development and progression | Triglycerides | Insulin | Fatty acids | Cholesterol | Fatty liver | Leptin | Collagen | Universities and colleges
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Blockade of interleukin-6 signaling enhances hepatic steatosis but improves liver injury in methionine choline-deficient diet-fed mice
by Yamaguchi, Kanji and Itoh, Yoshito and Yokomizo, Chihiro and Nishimura, Takeshi and Niimi, Toshihisa and Fujii, Hideki and Okanoue, Takeshi and Yoshikawa, Toshikazu
Laboratory Investigation, ISSN 0023-6837, 08/2010, Volume 90, Issue 8, pp. 1169 - 1178
Inflammatory processes have an important role in the development of hepatic steatosis and progression to nonalcoholic steatohepatitis (NASH). Interleukin-6... 
MCD diet | NASH | SREBP-1 | IL-6 | STAT3 | MEDICINE, RESEARCH & EXPERIMENTAL | METABOLIC SYNDROME | ACTIVATED PROTEIN-KINASE | REGENERATION | MOUSE | NONALCOHOLIC STEATOHEPATITIS | PATHOLOGY | INSULIN-RESISTANCE | IN-VIVO | RECEPTOR ANTIBODY | DISEASE | ADIPOSE-TISSUE | Choline - metabolism | PPAR alpha - adverse effects | Diet - adverse effects | Genes | Choline Deficiency - complications | Male | Alanine Transaminase - blood | Methionine - adverse effects | Fatty Liver - chemically induced | Choline - adverse effects | Choline Deficiency - metabolism | Interleukin-6 - metabolism | Sterol Regulatory Element Binding Protein 1 - metabolism | Methionine - deficiency | Fatty Liver - metabolism | Signal Transduction | Methionine - metabolism | Liver - metabolism | Mice, Inbred C57BL | Fatty Liver - prevention & control | Interleukin-6 - adverse effects | Animals | Mice | Alanine Transaminase - metabolism | PPAR alpha - metabolism | Lipid Peroxidation | Receptors, Interleukin-6 - metabolism
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text A simple scoring system using type IV collagen 7S and aspartate aminotransferase for diagnosing nonalcoholic steatohepatitis and related fibrosis
by Okanoue, Takeshi and Okanoue, Takeshi and Ebise, Hayao and Ebise, Hayao and Kai, Toshihiro and Kai, Toshihiro and Mizuno, Masayuki and Mizuno, Masayuki and Shima, Toshihide and Shima, Toshihide and Ichihara, Junji and Ichihara, Junji and Aoki, Mikio and Aoki, Mikio
Journal of Gastroenterology, ISSN 0944-1174, 1/2018, Volume 53, Issue 1, pp. 129 - 139
Recently we reported novel noninvasive scoring systems for diagnosing nonalcoholic steatohepatitis (NASH) and related fibrosis, namely FM-NASH index and... 
Noninvasive diagnosis | Biomarker | Nonalcoholic steatohepatitis | Medicine & Public Health | Colorectal Surgery | Hepatology | Gastroenterology | Abdominal Surgery | Liver fibrosis | Surgical Oncology | BARD SCORE | DOMAIN | FATTY LIVER-DISEASE | BIOPSY | VALIDATION | MARKERS | AREA | NAFLD FIBROSIS | FERRITIN | GASTROENTEROLOGY & HEPATOLOGY | EPIDEMIOLOGY | Collagen Type IV - blood | Predictive Value of Tests | Liver Cirrhosis - diagnosis | Humans | Middle Aged | Logistic Models | Male | Biomarkers - blood | Aspartate Aminotransferases - blood | Non-alcoholic Fatty Liver Disease - diagnosis | Liver Cirrhosis - pathology | Adult | Female | ROC Curve | Aged | Aspartate | Diagnosis | Collagen | Analysis | Liver | Fibrosis | Liver diseases | Fatty liver | Collagen (type IV) | Aspartate aminotransferase | Medical diagnosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Blockade of IL-6 signaling exacerbates liver injury and suppresses antiapoptotic gene expression in methionine choline-deficient diet-Fed db db mice
by Yamaguchi, Kanji and Itoh, Yoshito and Yokomizo, Chihiro and Nishimura, Takeshi and Niimi, Toshihisa and Umemura, Atsushi and Fujii, Hideki and Okanoue, Takeshi and Yoshikawa, Toshikazu
Laboratory Investigation, ISSN 0023-6837, 04/2011, Volume 91, Issue 4, pp. 609 - 618
Our previous study revealed that blockade of interleukin-6 (IL-6)-STAT3 signaling ameliorated liver injury, although hepatic STAT3(-/-) or GP130(-/-) mice have... 
IL-6 receptor | MCD diet | NASH | db/db mice | IL-6 | STAT3 | MEDICINE, RESEARCH & EXPERIMENTAL | HEPATOCYTES | REGENERATION | NONALCOHOLIC STEATOHEPATITIS | PATHOLOGY | INTERLEUKIN-6 | INSULIN-RESISTANCE | RECEPTOR ANTIBODY | IN-VIVO | DISEASE | LEPTIN RECEPTOR | HEPATIC STEATOSIS | Antibodies, Neutralizing - administration & dosage | Liver - pathology | Interleukin-6 - antagonists & inhibitors | Fatty Liver - pathology | Leptin - metabolism | Hepatocytes - pathology | Male | Choline Deficiency | DNA-(Apurinic or Apyrimidinic Site) Lyase - genetics | Receptors, Interleukin-6 - immunology | Methionine - deficiency | Gene Expression | Signal Transduction | Fatty Liver - physiopathology | Mice, Inbred C57BL | Injections, Intraperitoneal | Rats | Animals | Diet | Fibrosis | Proto-Oncogene Proteins c-bcl-2 - antagonists & inhibitors | DNA-(Apurinic or Apyrimidinic Site) Lyase - antagonists & inhibitors | Mice | STAT3 Transcription Factor - antagonists & inhibitors | Proto-Oncogene Proteins c-bcl-2 - genetics | Apoptosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text The combination of elbasvir and grazoprevir for the treatment of chronic HCV infection in Japanese patients: a randomized phase II/III study
by Kumada, Hiromitsu and Kumada, Hiromitsu and Suzuki, Yoshiyuki and Suzuki, Yoshiyuki and Karino, Yoshiyasu and Karino, Yoshiyasu and Chayama, Kazuaki and Chayama, Kazuaki and Kawada, Norifumi and Kawada, Norifumi and Okanoue, Takeshi and Okanoue, Takeshi and Itoh, Yoshito and Itoh, Yoshito and Mochida, Satoshi and Mochida, Satoshi and Toyoda, Hidenori and Toyoda, Hidenori and Yoshiji, Hitoshi and Yoshiji, Hitoshi and Takaki, Shintaro and Takaki, Shintaro and Yatsuzuka, Naoyoshi and Yatsuzuka, Naoyoshi and Yodoya, Etsuo and Yodoya, Etsuo and Iwasa, Takashi and Iwasa, Takashi and Fujimoto, Go and Fujimoto, Go and Robertson, Michael N and Robertson, Michael N and Black, Stuart and Black, Stuart and Caro, Luzelena and Caro, Luzelena and Wahl, Janice and Wahl, Janice
Journal of Gastroenterology, ISSN 0944-1174, 4/2017, Volume 52, Issue 4, pp. 520 - 533
Elbasvir (EBR) in combination with grazoprevir (GZR) has demonstrated efficacy in patients with hepatitis C virus (HCV) infections in trials primarily... 
Therapy | Medicine & Public Health | Colorectal Surgery | Hepatology | Gastroenterology | Abdominal Surgery | Clinical trial | Genotype | Efficacy | Surgical Oncology | Sustained virologic response | MK-8742 | MK-5172 | OPEN-LABEL | RIBAVIRIN | TRIAL | TREATMENT-NAIVE | HEPATITIS-C VIRUS | CIRRHOSIS | GENOTYPE 1 INFECTION | INHIBITOR | GASTROENTEROLOGY & HEPATOLOGY | Quinoxalines - adverse effects | Humans | Middle Aged | Drug Resistance, Viral | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Imidazoles - administration & dosage | Benzofurans - administration & dosage | Male | RNA, Viral - blood | Benzofurans - blood | Hepatitis C, Chronic - complications | Quinoxalines - blood | Young Adult | Aged, 80 and over | Adult | Female | Imidazoles - therapeutic use | Drug Therapy, Combination | Quinoxalines - therapeutic use | Hepacivirus - drug effects | Hepacivirus - isolation & purification | Liver Cirrhosis - drug therapy | Benzofurans - therapeutic use | Double-Blind Method | Drug Administration Schedule | Quinoxalines - administration & dosage | Administration, Oral | Antiviral Agents - blood | Antiviral Agents - therapeutic use | Imidazoles - adverse effects | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Benzofurans - adverse effects | Hepatitis C, Chronic - blood | Imidazoles - blood | Liver Cirrhosis - virology | Antiviral Agents - adverse effects | Aged | Sustained Virologic Response | Medicine, Experimental | Clinical trials | Medical research | Hepatitis C virus | Health aspects | Original —Liver, Pancreas, and Biliary Tract
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population
by Sumida, Yoshio and Yoneda, Masato and Hyogo, Hideyuki and Itoh, Yoshito and Ono, Masafumi and Fujii, Hideki and Eguchi, Yuichiro and Suzuki, Yasuaki and Aoki, Noriaki and Kanemasa, Kazuyuki and Fujita, Koji and Chayama, Kazuaki and Saibara, Toshiji and Kawada, Norifumi and Fujimoto, Kazuma and Kohgo, Yutaka and Yoshikawa, Toshikazu and Okanoue, Takeshi and JSG-NAFLD and Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD)
BMC Gastroenterology, ISSN 1471-230X, 01/2012, Volume 12, Issue 1, pp. 2 - 2
Background: A reliable and inexpensive noninvasive marker of hepatic fibrosis is required in patients with nonalcoholic fatty liver disease (NAFLD). FIB4 index... 
NAFLD | SIMPLE NONINVASIVE INDEX | CLINICAL SCORING SYSTEM | PREDICT | MARKER | SIGNIFICANT FIBROSIS | CIRRHOSIS | STEATOHEPATITIS | GASTROENTEROLOGY & HEPATOLOGY | IV COLLAGEN 7S | HYALURONIC-ACID | Liver Cirrhosis - ethnology | Predictive Value of Tests | Liver - pathology | Age Factors | Humans | Middle Aged | Male | Alanine Transaminase - blood | Fatty Liver - ethnology | Non-alcoholic Fatty Liver Disease | Adult | Female | Retrospective Studies | Severity of Illness Index | Liver Cirrhosis - diagnosis | Fatty Liver - blood | Japan | Liver Cirrhosis - blood | Fatty Liver - diagnosis | Platelet Count | Aspartate Aminotransferases - blood | Biopsy | Biomarkers | ROC Curve | Aged | Cohort Studies | Fatty liver | Research | Biological markers | Comparative analysis | Testing | Science | Hepatitis | Liver cirrhosis | Colleges & universities
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Is the grade of ballooned hepatocytes a significant risk factor for rapid progression of hepatic fibrosis in patients with NAFLD?
by Sumida, Yoshio and Yoneda, Masashi and Okanoue, Takeshi and JSG-NAFLD and Japan Study Group of Non-Alcoholic Fatty Liver Disease (JSG-NAFLD) and for the Japan Study Group of Non-Alcoholic Fatty Liver Disease (JSG-NAFLD)
Journal of Gastroenterology, ISSN 0944-1174, 5/2019, Volume 54, Issue 5, pp. 474 - 475
Abdominal Surgery | Medicine & Public Health | Colorectal Surgery | Surgical Oncology | Hepatology | Gastroenterology | GASTROENTEROLOGY & HEPATOLOGY | Hepatocytes | Liver | Fibrosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights